Enliven Therapeutics
ELVN
ELVN
36 hedge funds and large institutions have $74.5M invested in Enliven Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
9.54% more ownership
Funds ownership: 7.83% → 17.36% (+9.5%)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Holders
36
Holding in Top 10
1
Calls
$1.33M
Puts
$77K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$10.2M | |
| 3 | +$3.77M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.79M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$2.58M |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$472K | |
| 3 | -$388K | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$226K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$212K |